Induction of lacI mutations in Big Blue rats treated with tamoxifen and α-hydroxytamoxifen
Authors:
- Mugimane G. ManjanathaMMMugimane G. Manjanatha
- M. Matilde MarquesM. Matilde Marques
- Frederick A. BelandFBFrederick A. Beland
- 1 February 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 176 (1) , 37-45
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Understanding the genotoxicity of tamoxifen?Carcinogenesis, 2001
- Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifenCarcinogenesis, 2000
- Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen.Carcinogenesis, 1999
- N-Demethylation accompanies α-hydroxylation in the metabolic activation of tamoxifen in rat liver cellsCarcinogenesis, 1999
- Tamoxifen−DNA Adducts Detected in the Endometrium of Women Treated with TamoxifenChemical Research in Toxicology, 1999
- Lack of evidence from HPLC 32P-post-labelling for tamoxifenDNA adducts in the human endometriumCarcinogenesis, 1999
- Identification of the major tamoxifenDNA adducts in rat liver by mass spectroscopyCarcinogenesis, 1999
- DNA binding of tamoxifen and its analogues: identification of the tamoxifen-DNA adducts in rat liver.Toxicology Letters, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998